WS #12351

From 480 msgs · 5 key-dev
Holding: newest synthesis is 122d 5h old

Abbott posts solid Q2 2026 beat-and-raise, with revenue up 13% YoY to $12.59B, driven by Medical Devices and Cancer Diagnostics; raises FY26 EPS guidance.

Abbott Laboratories Q2 Beat-and-Raise

Abbott posts solid Q2 2026 beat-and-raise, with revenue up 13% YoY to $12.59B, driven by Medical Devices and Cancer Diagnostics; raises FY26 EPS guidance.

Full world state #12351 →

Abbott Laboratories Q2 Beat-and-Raise — World state #12351 · River